Top Employer-Paid Stories
Maryland proposes price cap on Ozempic
By Alan GoforthThe Maryland Prescription Drug Affordability Board's proposed upper payment limit could save around $5.8 million a year, proponents said, according to Maryland Matters.
The latest regulatory issues, trends and best practices in providing employer-paid benefits such as health insurance, 401(k) and retirement planning.
The Maryland Prescription Drug Affordability Board's proposed upper payment limit could save around $5.8 million a year, proponents said, according to Maryland Matters.